)
)
AroCell Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from AroCell
Access all reports
AroCell AB is a Swedish diagnostics company that develops and markets blood and urine sample tests primarily for monitoring cancer, particularly breast, prostate, and bladder cancers. Its main product is the AroCell TK 210 ELISA, an immunoassay kit that measures Thymidine Kinase 1 protein levels in blood samples, helping to assess cell proliferation in cancer patients. Another key product, UBC Rapid, is used for diagnosing and monitoring bladder cancer. AroCell is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
)
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
)
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Ticker symbol
AROC
Country
đžđȘ Sweden